Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Blue Sky Uranium Schedules Start of Drill Program for Ivana Uranium-Vanadium Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Crescita Therapeutics Inc T.CTX

Alternate Symbol(s):  CRRTF

Healthcare Biotechnology
Crescita Therapeutics Inc. is a commercial dermatology company with in-house research and development (R&D) and manufacturing capabilities. It offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. It operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:CTX)

Crescita Reports First Quarter 2025 Results

Business Wire 9 days ago

Crescita Reports Q4 and Fiscal 2024 Results

Business Wire March 18, 2025

Crescita Reports Third Quarter 2024 Results

Business Wire November 6, 2024

Crescita Therapeutics Announces Approval of Normal Course Issuer Bid

Business Wire September 24, 2024

Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024

Business Wire September 12, 2024

Crescita Reports Second Quarter 2024 Results

Business Wire August 7, 2024

Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years

Business Wire July 22, 2024

Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement

Business Wire July 19, 2024

Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World's Smallest Intradermal Delivery Device

Business Wire July 17, 2024
View More News ››

Opinion & Analysis (TSX:CTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:CTX)

Q4 results

  Qtr ending Skincare Licensing Manufacturing ...
lscfa - March 18, 2025

Crescita's Comeback: Strategic Growth and Key Acquisitions

https://substack.com/home/post/p-156966361
Rahil1234 - February 11, 2025

Mathieu Martin - Stocks and Stones

#5 - Crescita Therapeutics (TSX: CTX)   Those who’ve been following Crescita for a significant amount of time know...
Possibleidiot01 - October 23, 2024

addition to latest Atrium takeover report

https://mcusercontent.com/4bc421505c66d079778a0d0be/files/c84f1943-b069-7c62-f72d-87f54a469d3b/20240905_Atrium_Takeouts_Part_3.02.pdf...
Possibleidiot01 - September 5, 2024

Mathieu Martin - Stocks and Stones

Crescita Therapeutics (TSX: CTX) is firing on all cylinders. In the span of a week, CTX announced a distribution agreement for a...
Possibleidiot01 - August 9, 2024

$10M 4 yr contract

Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years LAVAL, Quebec--(BUSINESS WIRE)--July 22, 2024--Crescita...
lscfa - July 22, 2024
View more Bullboard ››

Forge Resources Corp.

Forge Resources Corp.

Forge Resources Corp. is a junior exploration company. The Company is engaged in the business of the exploration and ...
View More »